Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Incyte Stock Climbed 12.2% in November

TheMotleyFool

0 0

Why Incyte Stock Climbed 12.2% in November

Shares of Incyte (NASDAQ: INCY) gained 12.2% last month, according to data from S&P Global Market Intelligence. The pharmaceutical company's stock benefited from a strong third-quarter earnings release at the end of October and continued to climb in November, thanks to market momentum, news of upcoming presentations at the American Society of Hematology's annual conference, and an expedited Food and Drug Administration (FDA) drug review.